The recent outbreak of the COVID-19 (Coronavirus) and the related supply chain interruptions has highlighted the vulnerability of global supply chains. Initial concern related to shutdowns in China production but as this country worked through the issues and restarted...
A widespread awakening from the current coronavirus epidemic is how vulnerable the bio-pharmaceutical supply chain of the US is on supply from China. As the spread of COVID-19 has witnessed shortages of PPE, masks and ventilators causing loss of human lives, the issue...
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While the majority of cases result in mild symptoms, some progress to pneumonia and multi-organ failure. As of March 28, 2020, the...
In the wake of the Covid-19 pandemic, I and many others have witnessed our reliance on China and Asian countries for basic medical supplies (such as gowns, masks, gloves, and ventilators), leave aside many pharmaceuticals and active ingredients are made in China. This...
The Coronavirus pandemic is the gravest “Black Swan” event experienced over a century. Nassim Nicholas Taleb described it in his pioneering book, The Black Swan(1), as a large scale unpredictable and irregular event of massive consequence with an infinitesimally low...
The innovative therapy of Cell and Gene Therapy has imposed Draconian demands on the supply chain of the embryonic industry in terms of production batch of one, sixteen day vein to vein lead time, cryogenic preservation and cold-chain logistics, chain of custody,...